Abstract
3,4-Methylenedioxymethcathinone (methylone) and 3,4-methylenedioxypyrovalerone (MDPV) are new drugs of abuse that have gained worldwide popularity. These drugs are structurally similar to 3,4-methylenedioxymethamphetamine (MDMA) and share many of its physiological and behavioral effects in humans, including the development of hyperthermia during acute intoxication. Here, we examined the effects of methylone (1–9 mg/kg, s.c.) or MDPV (0.1–1.0 mg/kg, s.c.) on brain temperature homeostasis in rats maintained in a standard laboratory environment (single-housed in a quiet rest at 22 °C) and under conditions that model human drug use (social interaction and 29 °C ambient temperature). By simultaneously monitoring temperatures in the nucleus accumbens, temporal muscle, and facial skin, we assessed the effects of methylone and MDPV on intra-brain heat production and cutaneous vascular tone, two critical factors that control brain temperature responses. Both methylone and MDPV dose-dependently increased brain temperature, but even at high doses that induced robust locomotor activation, hyperthermia was modest in magnitude (up to ∼2 °C). Both drugs also induced dose-dependent peripheral vasoconstriction, which appears to be a primary mechanism determining the brain hyperthermic responses. In contrast to the powerful potentiation of MDMA-induced hyperthermia by social interaction and warm ambient temperature, such potentiation was absent for methylone and minimal for MDPV. Taken together, despite structural similarities to MDMA, exposure to methylone or MDPV under conditions commonly associated with human drug use does not lead to profound elevations in brain temperature and sustained vasoconstriction, two critical factors associated with MDMA toxicity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013). The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71: 130–140.
Badiani A, Belin D, Epstein D, Calu D, Shaham Y (2011). Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12: 685–700.
Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF et al (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37: 1192–1203.
Baumann MH, Partilla JS, Lehner KR (2013a). Psychoactive "bath salts": not so soothing. Eur J Pharmacol 698: 1–5.
Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M et al (2013b). Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology 38: 552–562.
Borek HA, Holstege CP (2012). Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone. Ann Emerg Med 60: 103–105.
Brown PL, Kiyatkin EA (2004). Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions. Eur J Neurosci 20: 51–58.
Brown PL, Wise RA, Kiyatkin EA (2003). Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J Neurosci 23: 3924–3929.
Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ (2013). Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168: 1750–1757.
DEA (2011). Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule 1. In: Administration DE (ed) Fed Regist 76 Vol Final Order pp 65371–65375.
Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013). Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85: 1803–1815.
Fantegrossi WE, Gannon BM, Zimmerman SM, Rice KC (2013). In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38: 563–573.
German CL, Fleckenstein AE, Hanson GR (2014). Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97: 2–8.
Kesha K, Boggs CL, Ripple MG, Allan CH, Levine B, Jufer-Phipps R et al (2013). Methylenedioxypyrovalerone ("bath salts"), related death: case report and review of the literature. J Forensic Sci 58: 1654–1659.
Kiyatkin EA (2010). Brain temperature homeostasis: physiological fluctuations and pathological shifts. Front Biosci 15: 73–92.
Kiyatkin EA (2013). The hidden side of drug action: brain temperature changes induced by neuroactive drugs. Psychopharmacology (Berl) 225: 765–780.
Kiyatkin EA, Brown PL (2004). Modulation of physiological brain hyperthermia by environmental temperature and impaired blood outflow in rats. Physiol Behav 83: 467–474.
Kiyatkin EA, Kim AH, Wakabayashi KT, Baumann MH, Shaham Y (2014). Critical role of peripheral vasoconstriction in fatal brain hypewrthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use. J Neurosci 34: 7754–7762.
Merluzzi AP, Hurwitz ZE, Briscione MA, Cobuzzi JL, Wetzell B, Rice KC et al (2013). Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats. Dev Psychobiol 56: 943–954.
Mogenson GJ, Jones DL, Yim CY (1980). From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14: 69–97.
Murray BL, Murphy CM, Beuhler MC (2012). Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV). J Med Toxicol 8: 69–75.
Pearson JM, Hargraves TL, Hair LS, Massucci CJ, Frazee CC 3rd, Garg U et al (2012). Three fatal intoxications due to methylone. J Anal Toxicol 36: 444–451.
Prosser JM, Nelson LS (2012). The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8: 33–42.
Romanovsky AA, Ivanov AI, Shimansky YP (2002). Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 92: 2667–2679.
Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA (2012). Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. Am J Med 125: 854–858.
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J et al (2013). Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168: 458–470.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011). Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49: 499–505.
Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF et al (2014). Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19: 165–174.
Wise RA (1989). The brain and reward. In: Liebman JM, Kooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press: Oxford. pp 377–424.
Acknowledgements
This study is supported by the National Institute on Drug Abuse, Intramural Research Program, NIH. The Authors declare no any financial interests in relation to the work described.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Kiyatkin, E., Kim, A., Wakabayashi, K. et al. Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV. Neuropsychopharmacol 40, 436–445 (2015). https://doi.org/10.1038/npp.2014.191
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2014.191
